Literature DB >> 31646290

Association between asymmetric dimethylarginine serum levels and left ventricular longitudinal deformation in patients with normal ejection fractions: a two-dimensional speckle-tracking echocardiography examination.

Ali Hosseinsabet1, Niloofar Akavan-Khaleghi1, Reza Mohseni-Badalabadi1.   

Abstract

OBJECTIVES: Nitric oxide is an endogenous substance that preserves the myocardial function in patients with heart failure. Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of endogenous nitric oxide synthase. We sought to explore the association between the left ventricular (LV) function as assessed with two-dimensional echocardiography and the serum level of ADMA in nondiabetic patients without significant coronary artery disease. PATIENTS AND METHODS: Eighty-seven consecutive patients with normal LV ejection fractions were included in this cross-sectional study. The ADMA serum level was measured, and the longitudinal deformation indices of the LV myocardium were evaluated using two-dimensional speckle-tracking echocardiography (2DSTE).
RESULTS: The systolic strain, the systolic strain rate, and the early and late diastolic strain rates as evaluated with 2DSTE were not statistically significantly different between the patients with normal ADMA serum levels and those with increased ADMA serum levels. The two study groups were also not significantly different in terms of the systolic and diastolic myocardial velocities obtained with tissue Doppler.
CONCLUSION: Our findings showed no statistically significant correlations between the serum ADMA level and the 2DSTE-derived indices of the longitudinal deformation of the LV myocardium in our nondiabetic patients without significant coronary artery stenosis and with normal LV ejection fractions.
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Keywords:  asymmetric dimethylarginine; left ventricle; two-dimensional speckle-tracking echocardiography

Year:  2018        PMID: 31646290      PMCID: PMC6739854          DOI: 10.1097/XCE.0000000000000158

Source DB:  PubMed          Journal:  Cardiovasc Endocrinol Metab        ISSN: 2574-0954


  25 in total

Review 1.  A practical approach to using strain echocardiography to evaluate the left ventricle.

Authors:  Harvey Feigenbaum; Ronald Mastouri; Stephen Sawada
Journal:  Circ J       Date:  2012-06-09       Impact factor: 2.993

2.  Speckle tracking echocardiography: A new approach to myocardial function.

Authors:  Simona Sitia; Livio Tomasoni; Maurizio Turiel
Journal:  World J Cardiol       Date:  2010-01-26

3.  Reference intervals of plasma matrix metalloproteinases 2, 3, and 9 and serum asymmetric dimethylarginine levels.

Authors:  Pavlina Kusnierova; Frantisek Vsiansky; Leos Pleva; Pavlina Plevova; Kristian Safarcik; Zdenek Svagera
Journal:  Scand J Clin Lab Invest       Date:  2015-07-07       Impact factor: 1.713

4.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

Review 5.  Myocardial strain to detect subtle left ventricular systolic dysfunction.

Authors:  Laurens F Tops; Victoria Delgado; Nina Ajmone Marsan; Jeroen J Bax
Journal:  Eur J Heart Fail       Date:  2016-11-27       Impact factor: 15.534

6.  Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.

Authors:  Wai Hong Wilson Tang; Wilson Tong; Kevin Shrestha; Zeneng Wang; Bruce S Levison; Brian Delfraino; Bo Hu; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  Eur Heart J       Date:  2008-08-06       Impact factor: 29.983

7.  Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.

Authors:  Vinod Achan; Michael Broadhead; Mohammed Malaki; Guy Whitley; James Leiper; Raymond MacAllister; Patrick Vallance
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-12       Impact factor: 8.311

8.  Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertension.

Authors:  Rafał Poręba; Paweł Gać; Małgorzata Poręba; Arkadiusz Derkacz; Angelika Chachaj; Grzegorz Mazur; Andrzej Szuba
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

Review 9.  Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Toxins (Basel)       Date:  2017-03-06       Impact factor: 4.546

Review 10.  Nitric oxide synthases in heart failure.

Authors:  Ricardo Carnicer; Mark J Crabtree; Vidhya Sivakumaran; Barbara Casadei; David A Kass
Journal:  Antioxid Redox Signal       Date:  2012-09-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.